Zimmer Biomet Holdings (ZBH) is down 4.6% today. Here is some analysis on what might have caused this price movement.
Analysis: There does not appear to be a fresh Zimmer Biomet-specific filing or major corporate announcement tied directly to today’s selloff. The move looks more likely to reflect a broader medtech risk-off trade, with investors reacting to negative updates elsewhere in the medical device group and reassessing execution and supply-chain risks across orthopedic names.
Details:
Sources:
Zimmer Biomet, SEC, AP
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$ZBH Insider Trading Activity
$ZBH insiders have traded $ZBH stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $ZBH stock by insiders over the last 6 months:
- SANG YI (Group President, Asia Pacific) has made 0 purchases and 2 sales selling 5,000 shares for an estimated $413,216.
- LORI WINKLER (SVP and CHRO) sold 2,650 shares for an estimated $250,849
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$ZBH Hedge Fund Activity
We have seen 400 institutional investors add shares of $ZBH stock to their portfolio, and 481 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FRANKLIN RESOURCES INC removed 5,103,543 shares (-93.6%) from their portfolio in Q2 2026, for an estimated $439,364,016
- PRICE T ROWE ASSOCIATES INC /MD/ removed 3,202,555 shares (-40.0%) from their portfolio in Q2 2026, for an estimated $275,707,959
- CAPITAL INTERNATIONAL INVESTORS added 3,064,392 shares (+33.6%) to their portfolio in Q2 2026, for an estimated $263,813,507
- UBS GROUP AG added 1,385,250 shares (+100.9%) to their portfolio in Q2 2026, for an estimated $119,256,172
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 1,377,103 shares (+inf%) to their portfolio in Q2 2026, for an estimated $118,554,797
- VICTORY CAPITAL MANAGEMENT INC removed 1,325,043 shares (-53.5%) from their portfolio in Q2 2026, for an estimated $114,072,951
- AMERICAN CENTURY COMPANIES INC removed 1,218,743 shares (-30.8%) from their portfolio in Q2 2026, for an estimated $104,921,584
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$ZBH Government Contracts
We have seen $11,641,141 of award payments to $ZBH over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- BASE PLUS TWO YEAR SERVICE AGREEMENT. ROSA KNEE PREMIUM AND LITE WARRANTY: $197,500
- THE PURPOSE OF THIS DELIVERY ORDER IS TO PAY THE UNPAID INVOICES FOR FY24 AND FY25. THIS DELIVERY ORDER IS ...: $195,000
- 4571007457!ROSA 6 MONTH USAGE: $114,000
- PREVENTIVE MAINTENANCE AND REPAIR SERVICE FOR ROSA ONE BRAIN SYSTEM: $98,000
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
$ZBH Congressional Stock Trading
Members of Congress have traded $ZBH stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $ZBH stock by members of Congress over the last 6 months:
- SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$ZBH Price Targets
Multiple analysts have issued price targets for $ZBH recently. We have seen 10 analysts offer price targets for $ZBH in the last 6 months, with a median target of $95.0.
Here are some recent targets:
- Vik Chopra from BMO Capital set a target price of $95.0 on 07/09/2026
- Vijay Kumar from Evercore ISI Group set a target price of $110.0 on 07/06/2026
- Joanne Wuensch from Citigroup set a target price of $93.0 on 05/28/2026
- Richard Newitter from Truist Securities set a target price of $92.0 on 04/29/2026
- Rick Wise from Stifel set a target price of $105.0 on 04/29/2026
- David Turkaly from Citizens set a target price of $105.0 on 04/29/2026
- Larry Biegelsen from Wells Fargo set a target price of $90.0 on 04/29/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.